Related references
Note: Only part of the references are listed.Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation Treatment: Rural and Urban Trends in Medicare Beneficiaries
Faye L. Norby et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2022)
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
Amol D. Dhamane et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2022)
Time Trends and Treatment Pathways in Prescribing Individual Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: An Observational Study of More than Three Million Patients from Europe and the United States
Pareen Vora et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2022)
Heart Rhythm Society Atrial Fibrillation Centers of Excellence Study: A survey analysis of stakeholder practices, needs, and barriers
Roopinder K. Sandhu et al.
HEART RHYTHM (2022)
Trends in Uptake and Adherence to Oral Anticoagulation for Patients With Incident Atrial Fibrillation at High Stroke Risk Across Health Care Settings
Haran Yogasundaram et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)
Updating International Classification of Diseases 9th Revision to 10th Revision of a Claims-Based Frailty Index
Nileesa Gautam et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2021)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation
Wayne A. Ray et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation A Cohort Study
Dae Hyun Kim et al.
ANNALS OF INTERNAL MEDICINE (2021)
Measuring Frailty in Administrative Claims Data: Comparative Performance of Four Claims-Based Frailty Measures in the US Medicare Data
Dae Hyun Kim et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2020)
Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data
Utibe R. Essien et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION (2020)
Factors associated with non-prescription of oral anticoagulant treatment in non-valvular atrial fibrillation patients with dementia: a CPRD-HES study
Megan Besford et al.
AGE AND AGEING (2020)
Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective
Jonathan P. Piccini et al.
HEART RHYTHM (2020)
The NCDR Left Atrial Appendage Occlusion Registry
James Freeman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines-Atrial Fibrillation
Frederik Dalgaard et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study
Dae Hyun Kim et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2019)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
Craig T. January et al.
CIRCULATION (2019)
Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation Insights From the Veterans Health Administration
Alexander C. Perino et al.
CIRCULATION (2019)
Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial
Karen P. Alexander et al.
AMERICAN HEART JOURNAL (2019)
Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index
Dae Hyun Kim et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2018)
The market for oral anticoagulants
Stephen Bielecki et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Burden of Atrial Fibrillation-Associated Ischemic Stroke in the United States
Mohamad Alkhouli et al.
JACC-CLINICAL ELECTROPHYSIOLOGY (2018)
Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark
Kasper Gadsboll et al.
EUROPEAN HEART JOURNAL (2017)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2016)
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Emily C. O'Brien et al.
AMERICAN HEART JOURNAL (2014)
Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: Findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
Emily C. O'Brien et al.
AMERICAN HEART JOURNAL (2014)
Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
Jonathan L. Halperin et al.
CIRCULATION (2014)
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
Sigrun Halvorsen et al.
EUROPEAN HEART JOURNAL (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Atrial Fibrillation, Stroke, and Anticoagulation in Medicare Beneficiaries: Trends by Age, Sex, and Race, 1992-2010
Gautam R. Shroff et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Oral anticoagulants in older adults with atrial fibrillation
Gwen M. Bernacki et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries, 1993-2007
Jonathan P. Piccini et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2012)
A combined comorbidity score predicted mortality in elderly patients better than existing scores
Joshua J. Gagne et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Apixaban in Patients with Atrial Fibrillation
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Robert G. Hart et al.
ANNALS OF INTERNAL MEDICINE (2007)
Major Hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation
Elaine M. Hylek et al.
CIRCULATION (2007)
Share Paper
